pentobarbital will lower the extent or result of ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Sturdy CYP3A4 inducers may lessen partiaprevir and ritonavir ranges, and thus diminished efficacy of Viekira PakWhile not advisable as a regimen course of action, hemodialy